Drug Shortage Report for AURO-ALENDRONATE

Last updated on 2021-04-30 History
Report ID 131951
Drug Identification Number 02388553
Brand name AURO-ALENDRONATE
Common or Proper name ALENDRONATE
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 70MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 1x4's
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-01-18
Estimated end date 2021-04-30
Actual end date 2021-04-20
Shortage status Resolved
Updated date 2021-04-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-04-30 French Compare
v7 2021-04-30 English Compare
v6 2021-03-10 French Compare
v5 2021-03-10 English Compare
v4 2021-02-22 French Compare
v3 2021-02-22 English Compare
v2 2021-01-19 French Compare
v1 2021-01-19 English Compare

Showing 1 to 8 of 8